What is Phemi?
Phemi is a company in the process of launching its products and services, with a focus on data analysis and optimization solutions. While specific details are emerging, the company appears poised to serve businesses and individuals seeking to enhance their digital presence and operational efficiency. Phemi is actively engaging potential customers by encouraging subscriptions for updates on their upcoming debut, signaling a strategic approach to market entry and customer acquisition.
How much funding has Phemi raised?
Phemi has raised a total of $25M across 3 funding rounds:
Angel/Seed
$2.8M
Series A
$12.2M
Series B
$10M
Angel/Seed (2014): $2.8M with participation from Yaletown Venture Partners and BDC Venture Capital
Series A (2015): $12.2M led by British Columbia Discovery Fund, BDC Capital Healthcare Venture Fund, CTI Life Sciences Fund, and Yaletown Venture Partners
Series B (2017): $10M supported by GF Securities and BDC Healthcare Venture
Key Investors in Phemi
CTI Life Sciences Fund
CTI Life Sciences Fund is a prominent Canadian biotech venture capital firm that focuses on catalyzing innovative ideas and assets into scalable biotech companies. With over 20 years in business, the firm has made more than 30 investments across various therapeutic modalities, emphasizing both long-term value creation and expedited exit strategies.
Yaletown Venture Partners
Yaletown Partners focuses on transforming industries through technology investments that foster sustainable and impactful change. They specialize in driving transformative growth in innovative technology companies, particularly at the emerging growth stage. With a strong emphasis on collaboration and integrity, their experienced team supports entrepreneurs in scaling their businesses.
BDC Venture Capital
BDC Business Development Bank of Canada, founded in 1944 and headquartered in Montreal, Quebec, provides a wide range of financial and consulting services to small businesses, concentrating on technology and exporting.
What's next for Phemi?
The recent major strategic investment positions Phemi for significant scaling and market penetration. With a history of securing substantial capital, including Series A and Series B rounds, the company is well-equipped to execute its product launch strategy and expand its service offerings. Future developments will likely focus on leveraging data analytics to provide advanced optimization solutions, aiming to capture a notable share of its target market. Continued innovation and strategic partnerships will be key to Phemi's sustained growth and success in the competitive landscape.
See full Phemi company page
